ANDREA WALLACE: Open Payments
NPI 1497414213 · OLIVE BRANCH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,510 in 184 payments from 16 companies in 2025. Trend: 2023 $1,562 · 2024 $2,785 · 2025 $45,510
Consulting: $19,300Speaker / faculty: $10,390Travel & lodging: $8,403Food & beverage: $7,417
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 62 | $27,425 |
| Bayer Healthcare Pharmaceuticals Inc. | 23 | $10,064 |
| Abbott Laboratories | 58 | $3,662 |
| Alnylam Pharmaceuticals Inc. | 8 | $2,202 |
| Impulse Dynamics (USA) Inc. | 8 | $1,227 |
| AstraZeneca Pharmaceuticals LP | 7 | $215 |
| BridgeBio Pharma, Inc. | 6 | $209 |
| ABIOMED | 1 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $101 |
| Daxor Corporation | 1 | $95 |
Products named: Barostim Neo System, Kerendia, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Optimizer, CARDIOMEMS, AMVUTTRA, Attruby, WAINUA.
Industry payments across MS — which companies pay providers there.
